Relationship between single nucleotid polymorphisms and opioid analgesics and pain in cancer pain patients

Relationship between single nucleotid polymorphisms and opioid analgesics and pain in cancer pain patients - Single nucleotid polymorphisms and opioid analgesics

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000008595

Enrollment

200

Registered

2012-08-01

Start date

2012-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients with cancer pain and cancer-treatment related pain

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with cancer pain and/or cancer treatment related pain, who use any opioid analgesics

Exclusion criteria

Exclusion criteria: unconscious patients

Design outcomes

Primary

Measure	Time frame
single nucleotid polymorphisms	—

Countries

Japan

Contacts

Public ContactMasahiko Sumitani

The University of Tokyo Hospital Department of Anesthesiology and Pain Relief Center

sumitanim-ane@h.u-tokyo.ac.jp03-3815-5411

Outcome results